Cargando…

Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study

BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Kate, Scerif, Gaia, Astle, Duncan E, Fletcher, Paul C, Raymond, F Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369839/
https://www.ncbi.nlm.nih.gov/pubmed/25802558
http://dx.doi.org/10.1186/s11689-015-9105-x
_version_ 1782362798708228096
author Baker, Kate
Scerif, Gaia
Astle, Duncan E
Fletcher, Paul C
Raymond, F Lucy
author_facet Baker, Kate
Scerif, Gaia
Astle, Duncan E
Fletcher, Paul C
Raymond, F Lucy
author_sort Baker, Kate
collection PubMed
description BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with ID due to MAGUK gene mutations is higher than expected for the degree of general intellectual impairment, nor whether specific cognitive differences are associated with disruption to this gene functional network. METHODS: This study addresses these two questions via behavioural questionnaires and cognitive testing, applying quantitative methods previously validated in populations with ID. We compared males with X-linked ID caused by mutations in three MAGUK genes (PAK3, DLG3, OPHN1; n = 9) to males with ID caused by mutations in other X chromosome genes (n = 17). Non-parametric and parametric analyses were applied as appropriate to data. RESULTS: Groups did not differ in age, global cognitive impairment, adaptive function or epilepsy prevalence. However, individuals with MAGUK gene mutations demonstrated significantly higher psychopathology risks, comprising elevated total problem behaviours, prominent hyperactivity and elevated scores on an autism screening checklist. Despite these overt difficulties, individuals in the MAGUK group performed more accurately than expected for age and intelligence quotient (IQ) on computerised tests of visual attention, convergent with mouse models of MAGUK loss-of-function. CONCLUSIONS: Our findings support a role for MAGUK genes in influencing cognitive parameters relevant to psychiatric risk. In addition to establishing clear patterns of impairment for this group, our findings highlight the importance of careful phenotyping after genetic diagnosis, showing that gene functional network disruptions can be associated with specific psychopathological risks and cognitive differences within the context of ID. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11689-015-9105-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4369839
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43698392015-03-24 Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study Baker, Kate Scerif, Gaia Astle, Duncan E Fletcher, Paul C Raymond, F Lucy J Neurodev Disord Research BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with ID due to MAGUK gene mutations is higher than expected for the degree of general intellectual impairment, nor whether specific cognitive differences are associated with disruption to this gene functional network. METHODS: This study addresses these two questions via behavioural questionnaires and cognitive testing, applying quantitative methods previously validated in populations with ID. We compared males with X-linked ID caused by mutations in three MAGUK genes (PAK3, DLG3, OPHN1; n = 9) to males with ID caused by mutations in other X chromosome genes (n = 17). Non-parametric and parametric analyses were applied as appropriate to data. RESULTS: Groups did not differ in age, global cognitive impairment, adaptive function or epilepsy prevalence. However, individuals with MAGUK gene mutations demonstrated significantly higher psychopathology risks, comprising elevated total problem behaviours, prominent hyperactivity and elevated scores on an autism screening checklist. Despite these overt difficulties, individuals in the MAGUK group performed more accurately than expected for age and intelligence quotient (IQ) on computerised tests of visual attention, convergent with mouse models of MAGUK loss-of-function. CONCLUSIONS: Our findings support a role for MAGUK genes in influencing cognitive parameters relevant to psychiatric risk. In addition to establishing clear patterns of impairment for this group, our findings highlight the importance of careful phenotyping after genetic diagnosis, showing that gene functional network disruptions can be associated with specific psychopathological risks and cognitive differences within the context of ID. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11689-015-9105-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-27 2015 /pmc/articles/PMC4369839/ /pubmed/25802558 http://dx.doi.org/10.1186/s11689-015-9105-x Text en © Baker et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Baker, Kate
Scerif, Gaia
Astle, Duncan E
Fletcher, Paul C
Raymond, F Lucy
Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title_full Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title_fullStr Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title_full_unstemmed Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title_short Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
title_sort psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369839/
https://www.ncbi.nlm.nih.gov/pubmed/25802558
http://dx.doi.org/10.1186/s11689-015-9105-x
work_keys_str_mv AT bakerkate psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy
AT scerifgaia psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy
AT astleduncane psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy
AT fletcherpaulc psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy
AT raymondflucy psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy